252 related articles for article (PubMed ID: 16148455)
1. Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.
Ilan AB; Gevins A; Coleman M; ElSohly MA; de Wit H
Behav Pharmacol; 2005 Sep; 16(5-6):487-96. PubMed ID: 16148455
[TBL] [Abstract][Full Text] [Related]
2. Neurophysiological and cognitive effects of smoked marijuana in frequent users.
Hart CL; Ilan AB; Gevins A; Gunderson EW; Role K; Colley J; Foltin RW
Pharmacol Biochem Behav; 2010 Sep; 96(3):333-41. PubMed ID: 20600251
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
[TBL] [Abstract][Full Text] [Related]
4. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
[TBL] [Abstract][Full Text] [Related]
5. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
Heishman SJ; Stitzer ML; Yingling JE
Pharmacol Biochem Behav; 1989 Sep; 34(1):173-9. PubMed ID: 2560548
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
7. Marijuana's dose-dependent effects in daily marijuana smokers.
Ramesh D; Haney M; Cooper ZD
Exp Clin Psychopharmacol; 2013 Aug; 21(4):287-93. PubMed ID: 23937597
[TBL] [Abstract][Full Text] [Related]
8. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.
Cooper ZD; Haney M
Drug Alcohol Depend; 2009 Aug; 103(3):107-13. PubMed ID: 19443132
[TBL] [Abstract][Full Text] [Related]
9. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].
Morgan CJ; Schafer G; Freeman TP; Curran HV
Br J Psychiatry; 2010 Oct; 197(4):285-90. PubMed ID: 20884951
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
11. Effects of THC on behavioral measures of impulsivity in humans.
McDonald J; Schleifer L; Richards JB; de Wit H
Neuropsychopharmacology; 2003 Jul; 28(7):1356-65. PubMed ID: 12784123
[TBL] [Abstract][Full Text] [Related]
12. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.
Chait LD; Zacny JP
Psychopharmacology (Berl); 1992; 107(2-3):255-62. PubMed ID: 1319601
[TBL] [Abstract][Full Text] [Related]
13. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
[TBL] [Abstract][Full Text] [Related]
14. Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.
Böcker KB; Gerritsen J; Hunault CC; Kruidenier M; Mensinga TT; Kenemans JL
Pharmacol Biochem Behav; 2010 Jul; 96(1):67-74. PubMed ID: 20417659
[TBL] [Abstract][Full Text] [Related]
15. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
16. Effects of marijuana on neurophysiological signals of working and episodic memory.
Ilan AB; Smith ME; Gevins A
Psychopharmacology (Berl); 2004 Nov; 176(2):214-22. PubMed ID: 15502936
[TBL] [Abstract][Full Text] [Related]
17. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
Morgan CJ; Gardener C; Schafer G; Swan S; Demarchi C; Freeman TP; Warrington P; Rupasinghe I; Ramoutar A; Tan N; Wingham G; Lewis S; Curran HV
Psychol Med; 2012 Feb; 42(2):391-400. PubMed ID: 21798112
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
Cooper ZD; Comer SD; Haney M
Neuropsychopharmacology; 2013 Sep; 38(10):1984-92. PubMed ID: 23609132
[TBL] [Abstract][Full Text] [Related]
19. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
Haney M; Rabkin J; Gunderson E; Foltin RW
Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
[TBL] [Abstract][Full Text] [Related]
20. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.
Babalonis S; Haney M; Malcolm RJ; Lofwall MR; Votaw VR; Sparenborg S; Walsh SL
Drug Alcohol Depend; 2017 Mar; 172():9-13. PubMed ID: 28088032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
